In mid-July, our company witnessed a crucial milestone in the dual quality audits. The audit team from our partner, Xi'an Saite Simai Titanium Industry Co., Ltd., along with experts specializing in ISO 13485 medical device quality management system certification, arrived simultaneously. They conducted a thorough review of our entire titanium material production and processing process as well as product quality. This marked another authoritative validation of our company's quality management system in the medical-grade titanium materials sector.
Partner Audit: Deepening Collaboration, Building Quality Standards
Xi'an Saite Simai company, as an important domestic partner for high-end titanium alloy materials, dispatched a technical quality team to conduct a comprehensive assessment of our production line, testing laboratory, and supply chain management. The audit team focused on the composition control of medical titanium rods and plates, the uniformity of microstructure, and surface treatment processes, and verified the product traceability system. After rigorous review, the Setsmi team highly praised our intelligent precision processing equipment and the production process of medical-grade titanium materials in accordance with ASTM F136 standards. Both parties reached a deepening intention on long-term technical cooperation for titanium alloys used in orthopedic implants.
Medical System Certification: Empowering Upgrade, Expanding High-End Market
During the on-site audit of ISO 13485:2016 medical device quality management system, the certification experts conducted a comprehensive assessment of our company's quality control capabilities in the medical titanium materials sector through on-site verification and management interviews. The audit scope covered the entire process from raw material procurement, machining, aseptic cleaning to shipment inspection, with particular attention to data management of product biocompatibility and control of clean workshops. The expert group fully affirmed our company's achievements in the construction of medical device risk management, process verification, and customer complaint response mechanisms, marking that our company's production system for medical implant-grade titanium materials has fully aligned with international standards.
Through Audits to Enhance, Strengthen Industry Leadership
The general manager emphasized at the closing meeting: "The dual audits are not only a comprehensive inspection of the existing management system but also a strategic opportunity to drive quality upgrades. We will strictly follow the ISO 13485 medical system standards and continuously optimize the full chain quality control from titanium ore selection to the final product, providing more reliable titanium material solutions for high-end medical devices in the fields of orthopedics and dentistry."
The successful completion of this audit not only strengthened the mutual trust foundation with strategic partners but also laid a solid qualification guarantee for the company's entry into the global medical device supply chain. In the future, we will continue to fulfill the quality commitment of 'Zero Defects in Titanium Materials, 100% in Medical' and drive the upgrading of medical titanium alloy through technological innovation.